Stock SLNO SOLENO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Soleno Therapeutics, Inc.

Equities

SLNO

US8342033094

Market Closed - Nasdaq
Other stock markets
 21:00:00 20/05/2024 BST 		5-day change 1st Jan Change
47.01 USD +1.84% Intraday chart for Soleno Therapeutics, Inc. +9.84% +16.80%
05-13 Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating MT
05-10 Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Soleno Therapeutics, Inc. Announces Gwen Melincoff, Intends Not Intend to Stand for Re-Election as Director
CI
Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing
MT
Soleno Therapeutics Names Meredith Manning as Chief Commercial Officer
MT
Soleno Therapeutics Strengthens Leadership Team with Key Appointments
CI
Soleno Therapeutics Insider Sold Shares Worth $1,412,431, According to a Recent SEC Filing
MT
Soleno Therapeutics Insider Sold Shares Worth $1,182,828, According to a Recent SEC Filing
MT
Soleno Therapeutics Insider Sold Shares Worth $222,177, According to a Recent SEC Filing
MT
Soleno Therapeutics Insider Sold Shares Worth $1,471,049, According to a Recent SEC Filing
MT
Soleno Therapeutics Appoints Matthew Pauls to Board of Directors
CI
Insider Buy: Soleno Therapeutics
MT
Insider Sell: Soleno Therapeutics
MT
Insider Trends: Soleno Therapeutics Insider Continues 90-Day Selling Trend
MT
Soleno Therapeutics, Inc. Announces Executive Changes
CI
Soleno Therapeutics, Inc. Announces Executive Changes
CI
Soleno Therapeutics Appoints Birgitte Volck to its Board of Directors
CI
Soleno Therapeutics, Inc. Announces Management Changes
CI
Soleno Therapeutics, Inc. Announces Appointment of Andrew Sinclair in Board of Directors
CI
Soleno Therapeutics, Inc Announces Board Changes
CI
Soleno Therapeutics, Inc. Announces Board and Committee Changes
CI
Soleno Therapeutics, Inc. Appoints Jonathan Wolter as Chief Financial Officer on Non-Interim Basis
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SLNO Stock
  4. News Soleno Therapeutics, Inc.
  5. Insiders